Summary
PRA Health Sciences was selected to conduct a global program of studies that targeted 2,200+ patients with multiple sclerosis (MS). Although there were many challenges, the study team implemented a comprehensive risk-management plan that resulted in achieved recruitment goals and positioned the sponsor as a “Sponsor of Choice” in MS research.
Register to download
Program Challenges Strengthen Partnership
You may also be interested in:
Poster
Human Abuse Liability Studies: Not Your Traditional Phase I Study
Abuse potential refers to the likelihood for a drug to be used in nonmedical situations for its positive psychoactive effects. PRA Health Sciences’…
Newsletter
Industry Watch
In the third week of November, Industry Watch brings you news on the role played by gut microbiota in conditions such as Parkinson’s, MS, and…
Capability
Pain Studies at PRA Early Development Services
PRA Health Sciences offers a range of pain models to assess pain perception and the efficacy of experimental analgesics in healthy volunteers and…